Award Recipients Announced for the 2024 San Antonio Breast Cancer Symposium
SAN ANTONIO – The San Antonio Breast Cancer Symposium (SABCS) and the American Association for Cancer Research (AACR), an...
Breast Cancer Preventive Effects of Anastrozole Persist Long After Stopping Treatment
SAN ANTONIO — Breast cancer incidence among postmenopausal women at high risk for developing the disease continued to be...
A Polygenic Risk Score May Predict Future Breast Cancer in Patients With Early-stage Diagnoses
Patients diagnosed with abnormal breast cells were more likely to receive a later diagnosis of breast cancer if their...
Partial Breast Irradiation May be as Effective as Whole Breast Irradiation in Preventing Recurrence in Patients with Early Breast Cancer
10-year follow-up data supports earlier findings on recurrence and survival SAN ANTONIO — A 10-year follow-up study of breast...
Breast MRI May Be Safely Omitted From Diagnostic Workup in Certain Patients With Early-stage, HR-negative Breast Cancer
Preoperative MRI had no impact on five-year recurrence rates SAN ANTONIO – Patients with stage 1 or 2, hormone...
Long-term Follow-up Shows Estrogen Alone and Estrogen Plus Progestin Have Opposite Effects on Breast Cancer Incidence in Postmenopausal Women
Estrogen alone decreased, while adding progestin increased, breast cancer incidence SAN ANTONIO — Long-term follow-up results from two large,...
Patients with HR-positive Breast Cancer May Use Fertility Preservation and Assisted Reproductive Technologies Without Increased Risk of Recurrence
Study examined pregnancy and cancer outcomes among patients who paused endocrine therapy to conceive SAN ANTONIO – Using fertility...
Award Winners Named for the 2020 San Antonio Breast Cancer Symposium
SAN ANTONIO – The San Antonio Breast Cancer Symposium (SABCS) and the American Association for Cancer Research (AACR), an...
Oncotype DX Breast Recurrence Score Reveals Sex-related Differences in Mortality Prediction in Patients With Early-stage ER-positive Breast Cancer
PHILADELPHIA — The associations of breast cancer recurrence scores (RS) with mortality measured using Oncotype DX, a commercial diagnostic...
Omitting Radiation Therapy After Breast-Conserving Surgery May Not Impact 10-year Survival Rates for Older Patients With HR-positive Breast Cancer
SAN ANTONIO – Older patients with hormone receptor-positive breast cancer who did not receive radiation therapy after breast-conserving surgery...
Adjuvant Chemotherapy Might Not Add Benefit in Breast Cancer Patients who Have Excellent Response to Neoadjuvant Chemotherapy
“SAN ANTONIO – Pathological complete response (pCR) after neoadjuvant (presurgery) chemotherapy was associated with significantly lower recurrence risk and...
Breast Cancer Survivors Are Less Likely to Get Pregnant, but Often Have Healthy Babies and Good Long-term Health
SAN ANTONIO – A large meta-analysis of breast cancer survivors of childbearing age indicated that they are less likely...
Choice of Surgery May Affect Quality of Life for Young Breast Cancer Survivors
SAN ANTONIO: Younger breast cancer patients who underwent mastectomy reported lower breast satisfaction and poorer psychosocial and sexual well-being...
Indigenous American Ancestry May Be Associated with HER2-positive Breast Cancer
PHILADELPHIA – An increased proportion of Indigenous American (IA) ancestry was associated with a greater incidence of HER2-positive breast...
Preoperative Radiation May Improve Antitumor Immune Response in Most Common Form of Breast Cancer
SAN ANTONIO – Preoperative radiation improved T-cell infiltration (TCI) in patients with hormone receptor (HR)-positive, HER2-negative breast cancer when...
Award Winners Named for the 2019 San Antonio Breast Cancer Symposium
SAN ANTONIO — The San Antonio Breast Cancer Symposium (SABCS) and the American Association for Cancer Research (AACR), an...
MINDACT Trial Data Reveal Certain Women With Luminal Breast Cancer May Be Undertreated With Tamoxifen Alone
SAN ANTONIO — Among women with hormone receptor (HR)-positive, HER2-negative breast cancer with a high clinical risk (determined by tumor...
Genetic Profiling May Identify Patients with Breast Cancer Who Can Safely Omit Radiation Therapy After Breast-conserving Surgery
SAN ANTONIO – Patients with invasive breast cancer who had low scores on an investigational gene molecular signature had...
Potentially Targetable Fusion RNAs May Be More Common in Metastatic Breast Cancer Than Previously Realized
SAN ANTONIO – Comprehensive profiling of fusion RNAs present in a large cohort of metastatic breast tumors revealed unique...
A Protein That Helps Trap Bacteria May Contribute to Metastasis in a Mouse Model of Breast Cancer
PHILADELPHIA – The protein peptidyl arginine deiminase 4 (PAD4), which enables some immune cells to trap bacteria, promoted breast...
Neoadjuvant Chemotherapy May Help Some Breast Cancer Patients Skip Regional Nodal Irradiation
Treatment de-escalation may be an option for patients whose lymph nodes become cancer free after neoadjuvant treatment SAN ANTONIO...
A Prognostic Model May Predict Survival in African-American Women with Breast Cancer
NEW ORLEANS – A prognostic model developed using a machine learning approach could identify African-American breast cancer patients with...
Award Recipients Announced for the 2025 San Antonio Breast Cancer Symposium
SAN ANTONIO – The San Antonio Breast Cancer Symposium (SABCS) and the American Association for Cancer Research (AACR), an SABCS cosponsor, will honor...
Mobile Health Tool May Improve Quality of Life for Adolescent and Young Adult Breast Cancer Survivors
SAN ANTONIO – A mobile health (mHealth) intervention for adolescent and young adult breast cancer survivors that offered tailored...
Award Winners Named for the 2021 San Antonio Breast Cancer Symposium
SAN ANTONIO – The San Antonio Breast Cancer Symposium (SABCS) and the American Association for Cancer Research (AACR), an...
Gap in Breast Cancer Mortality Rates Between Black and White Women Has Narrowed Over Three Decades
Black women still have twice the rate of breast cancer death than their white counterparts PHILADELPHIA — For women...
Black Women With Breast Cancer May Have Worse Outcomes Than Peers Despite Similar Genetic Recurrence Scores
SAN ANTONIO – Non-Hispanic Black women with hormone receptor (HR)-positive/HER2-negative, lymph node-positive breast cancer had worse outcomes compared to...
BRCA-mutation Carriers With a History of Early-onset Breast Cancer May Benefit From Risk-reducing Surgery
SAN ANTONIO – Patients with germline BRCA mutations who were diagnosed with breast cancer at or before age 40...
Black Women Have Worse Breast Cancer Outcomes Despite Receiving Similar Treatment as White Women
SAN ANTONIO – Even with equivalent treatments in women with hormone receptor-positive, HER2-negative breast cancer, black women had significantly...
Combining Endocrine Therapy with a CDK4/6 Inhibitor Results In Similar Response Rates to Chemotherapy for High-Risk Luminal B Breast Cancer
SAN ANTONIO — Neoadjuvant treatment with the CDK4/6 inhibitor ribociclib (Kisqali) and the aromatase inhibitor letrozole (Femara) produced response...